Theravance Biopharma Inc (TBPH)
Capital Expenditure
$0.00
Quarterly · Period ending: · USD
TBPH Capital Expenditure
Latest reported$0.00period ending
Latest reported$0.00period ending
TBPH Quarterly CapEx (-$567.00K → $0.00)
Quarterly CapEx
High-resolution chart · PNG
TBPH capital expenditure history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| 0 | |
| 0 | |
| -8,000 | |
| 0 | |
| -34,000 | |
| 0 | |
| -190,000 | |
| -15,000 | |
| -36,000 | |
| -91,000 | |
| -677,000 | |
| -21,000 | |
| -852,000 | |
| -938,000 | |
| -266,000 | |
| 57,000 | |
| -113,000 | |
| -250,000 | |
| -444,000 | |
| -1,039,000 | |
| -156,000 | |
| -1,767,000 | |
| -1,244,000 | |
| -2,050,000 | |
| -2,368,000 | |
| -954,000 | |
| -1,303,000 | |
| -77,000 | |
| -576,000 | |
| -1,220,000 | |
| -1,500,000 | |
| -1,875,000 | |
| -1,094,000 | |
| -2,771,000 | |
| -255,000 | |
| -826,000 | |
| -738,000 | |
| -587,000 | |
| -400,000 | |
| -413,000 | |
| -638,000 | |
| -684,000 | |
| -606,000 | |
| -674,000 | |
| -710,000 | |
| -657,000 | |
| -765,000 | |
| -461,000 | |
| -261,000 | |
| -1,620,000 | |
| -1,066,000 | |
| -237,000 | |
| -691,000 | |
| -740,000 | |
| -261,000 | |
| -567,000 |